骨形成蛋白2 (BMP-2) 市場規模、佔有率和成長分析：按產品類型、劑型、應用、給藥方法、最終用戶和地區分類 - 行業預測，2026-2033年

2024 年全球骨形成蛋白2 (BMP-2) 市值為 29.2 億美元，預計到 2025 年將成長至 31.1 億美元，到 2033 年將成長至 51.5 億美元，在預測期（2026-2033 年）內複合成長率為 6.5%。

全球骨形成蛋白2 (BMP-2) 市場的主要驅動力是整形外科和脊椎外科領域對這種生物製藥日益成長的需求，而人口老化以及骨折和脊髓退化疾病發病率的上升進一步推動了這一需求。 FDA核准的BMP-2產品展現出卓越的治療效果，例如加速骨癒合，這促使醫療專業人員尋求自體移植的替代方案，以最大程度地減少手術部位併發症，從而推動了BMP-2需求的激增。隨著組織工程技術的進步，BMP-2的應用範圍正從脊椎融合手術擴展到牙科植體和創傷固定等領域。醫療設備製造商和生物技術公司之間的合作正在推動遞送系統的創新，在提高療效的同時降低劑量和相關成本。此外，人工智慧在BMP-2研發中的應用正在簡化研究流程，降低成本，並加速從發現到臨床應用的進程。

全球骨形成蛋白2 (BMP-2) 市場成長要素

隨著肌肉骨骼疾病發病率的上升和人口老化，關節重建和脊椎融合手術的需求日益成長。為此，外科醫生越來越關注能夠促進骨癒合和最大限度減少術後併發症的生物製藥。骨形成蛋白2 (BMP-2) 因其能夠提高骨癒合率和加速康復而備受認可，成為臨床實踐中的首選藥物。這一趨勢促使製藥公司拓展產品線，並提高其在醫療機構的應用。因此，BMP-2 在整形外科和創傷治療領域擁有穩定的需求，並透過改善全球患者的長期治療效果，推動了市場成長。

全球骨形成蛋白2 (BMP-2) 市場的限制因素

由於重組骨形成蛋白2 (BMP-2) 的生產流程複雜，全球BMP-2市場面臨嚴峻挑戰。此製程需要嚴格的無菌條件，導致成本高昂。如此高的價格往往超出許多醫療機構的預算，迫使臨床醫生在採購決策中傾向於選擇傳統的骨移植或更實惠的合成產品。這種成本敏感性阻礙了BMP-2療法的廣泛應用，尤其是在對成本高度敏感的醫療機構和報銷體系尚不完善的新興市場。因此，BMP-2治療的經濟負擔成為公共和私部門市場擴張的主要障礙。

骨形成蛋白2 (BMP-2) 全球市場趨勢

全球骨形成蛋白2 (BMP-2) 市場正呈現顯著的融合趨勢，逐漸融入更廣泛的再生醫學框架。生技公司正日益將BMP-2與先進的支架技術、幹細胞來源和創新的生長因子遞送系統結合，從而開發出針對複雜肌肉骨骼問題的綜合解決方案。這種融合不僅簡化了手術流程，顯著加快了患者康復速度並縮短了住院時間，而且還促進了製藥公司和醫療設備製造商之間的合作。與學術機構的合作正在推動新配方的研發，並將治療應用拓展到傳統脊椎融合手術以外的領域。 BMP-2在全球組織工程方法的演進中發揮著至關重要的作用。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球骨形成蛋白2 (BMP-2) 市場規模：依產品類型分類

• 重組人BMP-2
• 基於BM​​P-2的骨移植

全球骨形成蛋白2 (BMP-2) 市場規模：依形式分類

• 粉末
• 凝膠
• 鷹架底座

全球骨形成蛋白2 (BMP-2) 市場規模：依應用領域分類

• 脊椎固定
• 骨折修復
• 牙骨再生

全球骨形成蛋白2 (BMP-2) 市場規模：依給藥途徑分類

• 局部移植
• 注射

全球骨形成蛋白2 (BMP-2) 市場規模：依最終用戶分類

• 醫院
• 專業整形外科診所
• 牙醫診所

全球骨形成蛋白2 (BMP-2) 市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic plc
• Stryker Corporation
• Johnson & Johnson
• DePuy Synthes
• Zimmer Biomet Holdings, Inc.
• Smith+Nephew plc
• Orthofix Medical Inc.
• Bioventus Inc.
• Stryker Biologics
• Spineart SA
• NuVasive, Inc.
• Globus Medical, Inc.
• RTI Surgical Holdings, Inc.
• LifeNet Health
• Genzyme Corporation
• Baxter International Inc.
• SeaSpine Holdings Corporation
• Integra LifeSciences Holdings Corporation
• Arthrex, Inc.
• Kuros Biosciences AG

結論與建議

Global Bone Morphogenetic Protein (Bmp) 2 Market size was valued at USD 2.92 Billion in 2024 and is poised to grow from USD 3.11 Billion in 2025 to USD 5.15 Billion by 2033, growing at a CAGR of 6.5% during the forecast period (2026-2033).

The global market for bone morphogenetic protein-2 (BMP-2) is driven by the rising demand for this biologic in orthopedic and spinal surgeries, primarily due to the aging population and increased incidence of fractures and degenerative spine diseases. As healthcare professionals seek alternatives to autografts that minimize donor-site complications, the preference for BMP-2 has surged, propelled by FDA-approved products that demonstrate advantageous outcomes such as quicker bone fusion. The market is expanding beyond spinal fusion applications into dental implants and trauma fixation, coupled with advancements in tissue engineering. Collaborations between device manufacturers and biotech firms are fostering innovation in delivery systems, enhancing efficacy while reducing dosage requirements and associated costs. Additionally, the integration of AI in BMP-2 development streamlines research, cutting costs and accelerating the pathway from discovery to clinical application.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bone Morphogenetic Protein (Bmp) 2 market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bone Morphogenetic Protein (Bmp) 2 Market Segments Analysis

Global bone morphogenetic protein (bmp) 2 market is segmented by product type, form, application, delivery method, end user and region. Based on product type, the market is segmented into Recombinant Human BMP-2 and BMP-2-Based Bone Grafts. Based on form, the market is segmented into Powder, Gel and Scaffold-Based. Based on application, the market is segmented into Spinal Fusion, Bone Fracture Repair and Dental Bone Regeneration. Based on delivery method, the market is segmented into Local Implantation and Injectable. Based on end user, the market is segmented into Hospitals, Specialty Orthopedic Clinics and Dental Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bone Morphogenetic Protein (Bmp) 2 Market

The growing incidence of musculoskeletal disorders, alongside an increasing elderly demographic, results in a greater demand for joint replacement and spinal fusion surgeries. In response, surgeons are increasingly inclined toward biologic agents that enhance bone healing and minimize complications post-surgery. Bone Morphogenetic Protein-2 (BMP-2) is increasingly recognized for its ability to improve fusion rates and speed up recovery, making it a favored choice in clinical practice. This preference bolsters pharmaceutical companies to broaden their product offerings and drives higher utilization in healthcare facilities, ultimately contributing to market growth by ensuring consistent demand across orthopedic and trauma applications and enhancing long-term patient outcomes globally.

Restraints in the Global Bone Morphogenetic Protein (Bmp) 2 Market

The Global Bone Morphogenetic Protein (BMP) 2 market faces significant challenges due to the complex manufacturing processes associated with recombinant BMP-2, which demand rigorous aseptic procedures and contribute to elevated costs. These high prices often exceed the budgets of many healthcare facilities, prompting clinicians to lean towards traditional bone grafts or more affordable synthetic options when making procurement choices. This cost sensitivity hinders the broad acceptance of BMP-2 therapies, particularly within cost-sensitive healthcare settings and in developing markets where reimbursement mechanisms are still evolving. As a result, the financial burden of BMP-2 therapeutics serves as a major obstacle to its market expansion in both public and private sectors.

Market Trends of the Global Bone Morphogenetic Protein (Bmp) 2 Market

The Global Bone Morphogenetic Protein (BMP) 2 market is experiencing a significant trend towards integration within broader regenerative medicine frameworks. Biotech companies are increasingly merging BMP-2 with advanced scaffold technologies, stem cell sourcing, and innovative growth-factor delivery systems, enabling the development of comprehensive solutions for complex musculoskeletal issues. This convergence not only streamlines surgical procedures, significantly enhancing patient recovery and minimizing hospital stays, but also fosters collaborative efforts between pharmaceutical firms and device manufacturers. Academic partnerships are driving the creation of novel formulations, expanding therapeutic applications beyond traditional spinal fusion and positioning BMP-2 as pivotal in the evolution of tissue engineering approaches globally.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Bone Morphogenetic Protein (BMP) 2 Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Recombinant Human BMP-2
• BMP-2-Based Bone Grafts

Global Bone Morphogenetic Protein (BMP) 2 Market Size by Form & CAGR (2026-2033)

• Market Overview
• Powder
• Gel
• Scaffold-Based

Global Bone Morphogenetic Protein (BMP) 2 Market Size by Application & CAGR (2026-2033)

• Market Overview
• Spinal Fusion
• Bone Fracture Repair
• Dental Bone Regeneration

Global Bone Morphogenetic Protein (BMP) 2 Market Size by Delivery Method & CAGR (2026-2033)

• Market Overview
• Local Implantation
• Injectable

Global Bone Morphogenetic Protein (BMP) 2 Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Orthopedic Clinics
• Dental Clinics

Global Bone Morphogenetic Protein (BMP) 2 Market Size & CAGR (2026-2033)

• North America (Product Type, Form, Application, Delivery Method, End User)
  • US
  • Canada
• Europe (Product Type, Form, Application, Delivery Method, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Form, Application, Delivery Method, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Form, Application, Delivery Method, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Form, Application, Delivery Method, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DePuy Synthes
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith+Nephew plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Biologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spineart SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuVasive, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Globus Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RTI Surgical Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeNet Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genzyme Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SeaSpine Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuros Biosciences AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations